explore -WSS

explore

author：fashion 2025-09-29 00:38:45 - browse：91633

A sign of Gilead Sciences sits in front of its headquarter and next to a pedestrian crossing sign — health coverage from STAT — Justin Sullivan/Getty Images

The assault on the development of new lifesaving therapies continues apace. Recently, the First Appellate Division of California Appeals held that companies not only have to defend products they have developed and marketed, but also those they have not.

In 2001, Gilead secured FDA approval of tenofovir disoproxil fumarate (TDF), one of first medicines to treat HIV — a product still on the market, despite the potential side effect of causing skeletal and kidney damage. In the years that followed, the company invested in research leading to additional TDF-based regimens critical to the fight against HIV. It had also done preliminary work on a similar but different drug — tenofovir alafenamide fumarate (TAF) — for which it had early, although not definitive, evidence for safety and efficacy.

Ultimately, this medicine was shown to have a better side effect profile than TDF. Starting in 2018, plaintiffs began suing Gilead for negligently failing to develop TAF earlier, on the theory that it wanted to protect the profits from TDF. Now, the California court has agreed to let the suit proceed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： 'Patient friction coefficient' can gauge a clinical trial's patient burden

WSS

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Medical devices makers are asking for forgiveness, not permission

Study: Hearing aids may slow cognitive decline in those at risk

US soldier in North Korean custody after crossing DMZ line

House passes resolution saying Israel isn't a 'racist or apartheid state'

House passes resolution saying Israel isn't a 'racist or apartheid state'

hotspot

explore

hotspot

Peter Hotez and the public health issue of online harassment

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

With Wegovy coverage, Medicare patients may face high costs

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Sports medicine is finally prioritizing gender equality

US soldier in North Korean custody after crossing DMZ line

United colonoscopy coverage change 'may cost lives,' doctors say

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

explore

What we know about the American soldier detained in North Korea

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Pregnancy ages women, but effects reverse after delivery

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

What Kate Middleton's cancer revelation might teach the world

Flagship, Pfizer team up in deal worth up to $7 billion

hotspot

Wikipedia

leisure time

Wikipedia